Homepage - Optometry Advisor
Jonathan Chen, OD, FAAO, FSLS, urges clinicians not to abandon myopia management in their adult patients, and outlines special considerations for using ortho-k, multifocal contact lenses, and other myopia control strategies in these individuals.
FDA Alerts: New Optometry Drugs and Devices
Nov 15, 2024 · In the last month, the US Food and Drug Administration (FDA) has approved a generic equivalent of the drug Pataday ®, an allogeneic cell therapy to treat corneal edema secondary to corneal endothelial disease, and an intraocular pressure (IOP)-lowering device that can be worn as a goggle.. New Drug Approval. Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (Lupin): Ocular Allergy
Optometry in 2024: What to Expect for the New Year
Dec 21, 2023 · Top Achievements of 2023. Some treatments for DED have made their way through the 2023 pipeline and into pharmacies. Meibo ® (Bausch + Lomb) and Xdemvy ® (Tarsus) received FDA approval this year and the drugs have shown promise for treating evaporative DED and Demodex blepharitis, respectively, company press releases from the 2 drug manufacturers claim. 4,5
Myopia in Adults - Optometry Advisor
Nov 1, 2024 · Axial Elongation in Adult Myopia . Regular eye exams are important for all adults, particularly those experiencing myopia progression. During these visits, it is important for clinicians to measure axial length, due to its association with pathologic myopia. 3 An optical biometer can best measure axial length changes, but not all practices have one. . Among optometry practices that do utilize ...
Red Light Therapy Provides Myopia Control ... - Optometry Advisor
Nov 22, 2023 · As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug Administration (FDA) approval, it has demonstrated efficacy in clinical trials ...
Lens-Based Myopia Control: Know When to Treat and Expect Results
Dec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.
Progressive Lens Designs Can Affect Patient Experience
Jun 7, 2024 · Optometrists may see patients with presbyopia on a routine basis — 128 million of these individuals live in the US alone — but not all clinicians or their staff consider progressive lens designs when caring for these patients. 1,2 Since numerous progressive lens options exist, it may be easy for some eye care professionals to limit their lens selection to only a …
Multifocals for Myopia Management – More Than Meets the Eye
Dec 10, 2021 · Clinicians can utilize multifocal contact lenses and fit them in accordance with a patient’s line of sight to combat myopia progression, a study shows.
Glaucoma Risk Factors: Social Determinants Impact Outcomes
Oct 25, 2024 · Image Credit: Getty Images Brittany Wright, OD, MS, FAAO, identifies sociodemographic, economic and environmental factors affecting glaucoma care, and stresses how these variables may affect patient outcomes more than treatment.
A Clinician's Guide to Peripheral Iridotomy - Optometry Advisor
Dec 2, 2022 · Several states have recently enacted legislation which expands optometry’s scope of practice — many of them involving laser procedures. Jeff M. Miller, OD, of the Northeastern State University Oklahoma School of Optometry details the process of performing the laser peripheral iridotomy procedure and discusses pre, peri, and postoperative considerations.